Aging
proteins in the lens become increasingly aggregated and insoluble, contributing to
presbyopia. In this study, we investigated the ability of aggrelyte-2 (N,S-
diacetyl-
L-cysteine methyl
ester) to reverse the water insolubility of aged human
lens proteins and to decrease stiffness in cultured human and mouse
lenses. Water-insoluble
proteins (WI) of aged human
lenses (65-75 years) were incubated with aggrelyte-2 (500 μM) for 24 or 48 h. A control compound that lacked the S-acetyl group (aggrelyte-2C) was also tested. We observed 19%-30% solubility of WI upon treatment with aggrelyte-2. Aggrelyte-2C also increased
protein solubility, but its effect was approximately 1.4-fold lower than that of aggrelyte-2. The
protein thiol contents were 1.9- to 4.9-fold higher in the aggrelyte-2- and aggrelyte-2C-treated samples than in the untreated samples. The LC-MS/MS results showed Nε -acetyllysine (AcK) levels of 1.5 to 2.1 nmol/mg
protein and 0.6 to 0.9 nmol/mg
protein in the aggrelyte-2- and aggrelyte-2C-treated samples. Mouse (C57BL/6J)
lenses (incubated for 24 h) and human
lenses (incubated for 72 h) with 1.0 mM aggrelyte-2 showed significant decreases in stiffness with simultaneous increases in soluble
proteins (human
lenses) and
protein-AcK levels, and such changes were not observed in aggrelyte-2C-treated
lenses. Mass spectrometry of the solubilized
protein revealed AcK in all
crystallins, but more was observed in α-
crystallins. These results suggest that aggrelyte-2 increases
protein solubility and decreases lens stiffness through acetylation and
disulfide reduction. Aggrelyte-2 might be useful in treating
presbyopia in humans.